Goldman Sachs BDC Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy

51

GSBD
Goldman Sachs BDC

Last Price:

14.35

Seasonality Move:

-0.05%

Sell

19

APLS
Apellis Pharmaceuticals

Last Price:

32.49

Seasonality Move:

18.8%

Buy

51

Goldman Sachs BDC (GSBD) is a Buy

Is Goldman Sachs BDC a Buy, Sell or Hold?

The current Goldman Sachs BDC [GSBD] share price is $14.35. The Score for GSBD is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
GSBD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

19

Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

GSBD Stock Price Chart

What is Goldman Sachs BDC's stock price today?

The Goldman Sachs BDC share price today is $14.35
The current trend is relatively stagnant and GSBD is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

The Apellis Pharmaceuticals share price today is $32.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

GSBD Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0	Sell
Relative Strength Index (14 RSI):	55.41	Buy
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(13.93 - 14.27)	Buy
Bollinger Bands (100):	(14.27 - 15.59)	Sell

APLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.84	Sell
Relative Strength Index (14 RSI):	33.6	Sell
Chaikin Money Flow:	-1084788	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(36.37 - 40.01)	Sell
Bollinger Bands (100):	(36.55 - 42.35)	Sell

GSBD Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	14.24	Buy
20-day SMA:	14.13	Buy
50-day SMA:	14.41	Sell
200-day SMA:	15.02	Sell
8-day EMA:	14.26	Buy
20-day EMA:	14.19	Buy
50-day EMA:	14.4	Sell
200-day EMA:	14.82	Sell

APLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	36.19	Sell
20-day SMA:	38.04	Sell
50-day SMA:	37.88	Sell
200-day SMA:	50	Sell
8-day EMA:	35.96	Sell
20-day EMA:	37.21	Sell
50-day EMA:	38.25	Sell
200-day EMA:	45.7	Sell

Goldman Sachs BDC Earnings Growth & GSBD Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.31 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Goldman Sachs BDC Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):